• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Access in therapeutic apheresis.

作者信息

Stegmayr Bernd, Wikdahl Ann Marie

机构信息

Division of Nephrology, Department of Internal Medicine, University Hospital, Norrlands Universitets Sjukhus, Umeå, Sweden.

出版信息

Ther Apher Dial. 2003 Apr;7(2):209-14. doi: 10.1046/j.1526-0968.2003.00035.x.

DOI:10.1046/j.1526-0968.2003.00035.x
PMID:12918945
Abstract

Various modes may be used to perform apheresis, such as plasma exchange, plasmapheresis, immunoadsorption, and blood perfusion. The vascular access used for acute procedures may be sufficiently supplied by two peripheral veins or catheters placed in the femoral vein or the right internal jugular vein. For chronic treatment it might be necessary to place an arteriovenous fistula or graft. The risks involved when using the various accesses is discussed, as is the insertion technique of the femoral vein catheter. The insertion of catheters into larger vessels is preferably controlled by ultrasound guidance. The incidence of adverse events due to access problems is about 0.4%. Once in every 1000 planned procedures, a problem with the access will cause an interruption of apheresis. Other complications that may occur are infections and thrombosis. Long-term use of particularly subclavian vein catheters more frequently results in stenosis than the use of other accesses. The placement of a femoral vein catheter is facilitated by outward rotation of the leg. In addition, other practical suggestions are given.

摘要

相似文献

1
Access in therapeutic apheresis.
Ther Apher Dial. 2003 Apr;7(2):209-14. doi: 10.1046/j.1526-0968.2003.00035.x.
2
[Access for starting kidney replacement therapy: vascular and peritoneal temporal access in pre-dialysis].[开始肾脏替代治疗的通路:透析前的血管和腹膜临时通路]
Nefrologia. 2008;28 Suppl 3:105-12.
3
Vascular access for apheresis in intensive care patients.重症监护患者单采术的血管通路
Ther Apher Dial. 2003 Apr;7(2):215-20. doi: 10.1046/j.1526-0968.2003.00039.x.
4
Thromboembolism following removal of femoral venous apheresis catheters in patients with breast cancer.乳腺癌患者股静脉血液成分分离导管拔除后的血栓栓塞
Ann Oncol. 2004 Sep;15(9):1366-72. doi: 10.1093/annonc/mdh347.
5
Upper body central venous catheters in pediatric cardiac surgery.小儿心脏手术中的上肢中心静脉导管
Paediatr Anaesth. 2013 Nov;23(11):980-8. doi: 10.1111/pan.12261. Epub 2013 Sep 19.
6
Mediastinal approach to the placement of tunneled hemodialysis catheters in patients with central vein occlusion in an outpatient access center.在门诊血管通路中心,针对中心静脉闭塞患者采用纵隔入路放置带隧道的血液透析导管。
J Vasc Access. 2011 Jul-Sep;12(3):258-61. doi: 10.5301/JVA.2010.6084.
7
The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis.股静脉置管与锁骨下静脉和颈内静脉置管相比与导管相关血流感染的风险:文献系统评价和荟萃分析。
Crit Care Med. 2012 Aug;40(8):2479-85. doi: 10.1097/CCM.0b013e318255d9bc.
8
Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial.与中心静脉置管相关的股深静脉血栓形成:一项前瞻性随机试验的结果
Crit Care Med. 1995 Jan;23(1):52-9. doi: 10.1097/00003246-199501000-00011.
9
Two single-lumen noncuffed catheters in the jugular vein as long-term vascular access: a preliminary report.两条颈内静脉单腔无套囊导管作为长期血管通路:初步报告
Ther Apher Dial. 2011 Jun;15(3):311-4. doi: 10.1111/j.1744-9987.2011.00957.x.
10
Side-effects and complications in large-bore catheters for apheresis.
Ther Apher Dial. 2003 Apr;7(2):221-4. doi: 10.1046/j.1526-0968.2003.00033.x.

引用本文的文献

1
Repeated small-volume exchange transfusion for hyperleukocytosis in pediatric acute leukemia: A retrospective analysis.小儿急性白血病高白细胞血症的重复小容量换血治疗:一项回顾性分析。
Front Pediatr. 2023 Mar 22;11:1155481. doi: 10.3389/fped.2023.1155481. eCollection 2023.
2
Real-world application of plasmapheresis for neurological disease: Results from the Japan-Plasmapheresis Outcome and Practice Patterns Study.真实世界中血浆置换在神经疾病中的应用:来自日本血浆置换结局和实践模式研究的结果。
Ther Apher Dial. 2023 Feb;27(1):123-135. doi: 10.1111/1744-9987.13906. Epub 2022 Jul 17.
3
International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.
国际小儿外科肿瘤学会(IPSO)手术实践指南
Ecancermedicalscience. 2022 Feb 17;16:1356. doi: 10.3332/ecancer.2022.1356. eCollection 2022.
4
Management of Hyperleukocytosis.高白细胞血症的管理
Curr Treat Options Oncol. 2016 Feb;17(2):7. doi: 10.1007/s11864-015-0387-8.
5
Short-term central venous catheter complications in patients with sickle cell disease who undergo apheresis.镰状细胞病患者行血细胞单采术时的短期中心静脉导管并发症。
J Thromb Thrombolysis. 2014;37(2):97-101. doi: 10.1007/s11239-013-0914-z.
6
Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.血浆置换可逆转顺铂过量的所有副作用——病例报告及治疗建议
BMC Cancer. 2006 Jan 4;6:1. doi: 10.1186/1471-2407-6-1.